Utilizing the Bradford Hill criteria reveals insufficient evidence for a direct causal link between GLP-1 agonists and STB
These properties meant exenatide could potentially be injected at intervals (e.g
XL: Supervision, Validation, Writing review and editing
Among the outcome estimates, significant reductions were reported in 13 of 17 for major adverse cardiovascular events (MACE), 5 of 8 for cardiovascular mortality, 3 of 4 for cardiovascular disease (CVD) events, 1 of 3 for cardiovascular death, and 1 of 1 for composite cardiovascular outcomes
It has been done with an average of 8 sessions with maximum one session per week
Heres how the authors explained this this: in the early stages of the disease, the gut makes a lot of GLP-1 to manage blood sugar